The purpose of this study is to better understand tobacco outcomes using a well-known stop
smoking medication, varenicline, and financial incentives with tobacco users. The
investigators are also interested in how cannabis/marijuana and tobacco interact during a
tobacco quit attempt. All participants will receive tobacco cessation treatment (varenicline)
for 12 weeks. This study will recruit adult tobacco users (ages 18-40) who are motivated to
quit smoking cigarettes.
Phase:
Phase 4
Details
Lead Sponsor:
Medical University of South Carolina
Collaborators:
National Cancer Institute (NCI) National Institutes of Health (NIH)